Keeping Your Practice Viable in Turbulent Times: A Roundtable Discussion
Price: FREE to College members, $25 non-members
COVID-19 has forced allergists to rethink and retool several aspects of their practice. In this roundtable discussion allergy experts from all practice sizes discuss challenges they have faced, strategies they’ve employed to be successful, and what they are doing now to keep their practices viable. Topics include:
- Growth opportunities to target.
- Strategies to manage expenses.
- Operational and safety protocol changes during COVID-19 and beyond.
- Telemedicine strategies for the future.
Supported by Sanofi Genzyme and Regeneron Pharmaceuticals, Inc.
This webcast is provided for general information purposes only and does not constitute accounting, legal, tax, or other professional advice. It is the opinion of the speakers only. They provide content they believe is true and accurate as of the date of the webcast; however, they give no assurance or warranty regarding the accuracy, timeliness, or applicability of any of the contents.
The American College of Allergy, Asthma, and Immunology accepts no responsibility for information presented during this webcast and disclaims all liability in respect of such information, including but not limited to any liability for errors, inaccuracies, omissions, or misleading or defamatory statements. You should not act upon the content or information in this webcast without first seeking appropriate advice from an accountant, lawyer or other professional.
The discussion is moderated by James Tracy, DO, FACAAI, chair of the Advocacy Council of ACAAI. Roundtable participants include Practice Management Committee members Priya Bansal, MD, FACAAI, Charlie Furr, Jr. and Mike Tankersley, MD, MBA, FACAAI.